C
Innoviva, Inc.
INVA
$17.09
-$0.20-1.16%
C
Hold
3/3/2025Downgrade
Innoviva, Inc. (INVA) was downgraded to C- from C on 3/3/2025 due to a decline in the volatility index.
Innoviva, Inc. (INVA) was downgraded to C- from C on 3/3/2025 due to a decline in the volatility index.
C
Hold
2/28/2025Downgrade
Innoviva, Inc. (INVA) was downgraded to C from C+ on 2/28/2025 due to a significant decline in the valuation index, total return index and growth index.
Innoviva, Inc. (INVA) was downgraded to C from C+ on 2/28/2025 due to a significant decline in the valuation index, total return index and growth index.
C
Hold
11/8/2024Upgraded
Innoviva, Inc. (INVA) was upgraded to C+ from C on 11/8/2024 due to a major increase in the growth index and solvency index. Earnings per share increased from -$0.5547 to $0.0194, and operating cash flow increased 11.36% from $43.72M to $48.69M.
Innoviva, Inc. (INVA) was upgraded to C+ from C on 11/8/2024 due to a major increase in the growth index and solvency index. Earnings per share increased from -$0.5547 to $0.0194, and operating cash flow increased 11.36% from $43.72M to $48.69M.
C
Hold
9/16/2024Downgrade
Innoviva, Inc. (INVA) was downgraded to C from C+ on 9/16/2024 due to a decline in the valuation index and volatility index.
Innoviva, Inc. (INVA) was downgraded to C from C+ on 9/16/2024 due to a decline in the valuation index and volatility index.
C
Hold
8/16/2024Upgraded
Innoviva, Inc. (INVA) was upgraded to C+ from C on 8/16/2024 due to a substantial increase in the total return index and volatility index.
Innoviva, Inc. (INVA) was upgraded to C+ from C on 8/16/2024 due to a substantial increase in the total return index and volatility index.
C
Hold
5/14/2024Downgrade
Innoviva, Inc. (INVA) was downgraded to C from C+ on 5/14/2024 due to a major decline in the total return index, growth index and efficiency index. EBIT declined 43.3% from $45.51M to $25.81M, net income declined 40.63% from $61.53M to $36.53M, and earnings per share declined from $0.7613 to $0.462.
Innoviva, Inc. (INVA) was downgraded to C from C+ on 5/14/2024 due to a major decline in the total return index, growth index and efficiency index. EBIT declined 43.3% from $45.51M to $25.81M, net income declined 40.63% from $61.53M to $36.53M, and earnings per share declined from $0.7613 to $0.462.
C
Hold
3/1/2024Upgraded
Innoviva, Inc. (INVA) was upgraded to C+ from C on 3/1/2024 due to a significant increase in the total return index, volatility index and solvency index. Debt to equity declined from 0.71 to 0.66, and the quick ratio increased from 6.85 to 7.28.
Innoviva, Inc. (INVA) was upgraded to C+ from C on 3/1/2024 due to a significant increase in the total return index, volatility index and solvency index. Debt to equity declined from 0.71 to 0.66, and the quick ratio increased from 6.85 to 7.28.
C
Hold
6/27/2023Upgraded
Innoviva, Inc. (INVA) was upgraded to C from C- on 6/27/2023 due to an increase in the total return index and volatility index.
Innoviva, Inc. (INVA) was upgraded to C from C- on 6/27/2023 due to an increase in the total return index and volatility index.
C
Hold
5/18/2023Upgraded
Innoviva, Inc. (INVA) was upgraded to C- from D+ on 5/18/2023 due to a large increase in the growth index, solvency index and valuation index. Operating cash flow increased 188.62% from $8.9M to $25.68M, earnings per share increased from -$0.9807 to $0.4185, and the quick ratio increased from 2.63 to 5.76.
Innoviva, Inc. (INVA) was upgraded to C- from D+ on 5/18/2023 due to a large increase in the growth index, solvency index and valuation index. Operating cash flow increased 188.62% from $8.9M to $25.68M, earnings per share increased from -$0.9807 to $0.4185, and the quick ratio increased from 2.63 to 5.76.
D
Sell
4/18/2023Downgrade
Innoviva, Inc. (INVA) was downgraded to D+ from C- on 4/18/2023 due to a decline in the total return index, valuation index and volatility index.
Innoviva, Inc. (INVA) was downgraded to D+ from C- on 4/18/2023 due to a decline in the total return index, valuation index and volatility index.
C
Hold
3/21/2023Upgraded
Innoviva, Inc. (INVA) was upgraded to C- from D+ on 3/21/2023 due to an increase in the volatility index and valuation index.
Innoviva, Inc. (INVA) was upgraded to C- from D+ on 3/21/2023 due to an increase in the volatility index and valuation index.
D
Sell
3/6/2023Downgrade
Innoviva, Inc. (INVA) was downgraded to D+ from C- on 3/6/2023 due to a decline in the volatility index and total return index.
Innoviva, Inc. (INVA) was downgraded to D+ from C- on 3/6/2023 due to a decline in the volatility index and total return index.
C
Hold
3/1/2023Downgrade
Innoviva, Inc. (INVA) was downgraded to C- from C on 3/1/2023 due to a substantial decline in the growth index, total return index and solvency index. Earnings per share declined from $2.8039 to -$0.9807, operating cash flow declined 43.28% from $15.69M to $8.9M, and debt to equity increased from 0.84 to 0.96.
Innoviva, Inc. (INVA) was downgraded to C- from C on 3/1/2023 due to a substantial decline in the growth index, total return index and solvency index. Earnings per share declined from $2.8039 to -$0.9807, operating cash flow declined 43.28% from $15.69M to $8.9M, and debt to equity increased from 0.84 to 0.96.
C
Hold
11/15/2022Upgraded
Innoviva, Inc. (INVA) was upgraded to C from C- on 11/15/2022 due to a major increase in the growth index, valuation index and efficiency index. Net income increased 28,177.21% from $939 to $265.52M, earnings per share increased from $0.0135 to $2.8039, and total capital increased 6.91% from $1.11B to $1.19B.
Innoviva, Inc. (INVA) was upgraded to C from C- on 11/15/2022 due to a major increase in the growth index, valuation index and efficiency index. Net income increased 28,177.21% from $939 to $265.52M, earnings per share increased from $0.0135 to $2.8039, and total capital increased 6.91% from $1.11B to $1.19B.
C
Hold
9/15/2022Downgrade
Innoviva, Inc. (INVA) was downgraded to C- from C on 9/15/2022 due to a decline in the total return index and volatility index.
Innoviva, Inc. (INVA) was downgraded to C- from C on 9/15/2022 due to a decline in the total return index and volatility index.
C
Hold
7/28/2022Downgrade
Innoviva, Inc. (INVA) was downgraded to C from C+ on 7/28/2022 due to a significant decline in the growth index, valuation index and efficiency index. Net income declined 94.05% from $15.77M to $939, earnings per share declined from $0.1957 to $0.0135, and operating cash flow declined 19.44% from $98.1M to $79.04M.
Innoviva, Inc. (INVA) was downgraded to C from C+ on 7/28/2022 due to a significant decline in the growth index, valuation index and efficiency index. Net income declined 94.05% from $15.77M to $939, earnings per share declined from $0.1957 to $0.0135, and operating cash flow declined 19.44% from $98.1M to $79.04M.
C
Hold
6/9/2022Downgrade
Innoviva, Inc. (INVA) was downgraded to C+ from B- on 6/9/2022 due to a significant decline in the growth index, total return index and solvency index. The quick ratio declined from 53.77 to 2.84, debt to equity increased from 0.95 to 1.4, and EBIT declined 27.91% from $107.83M to $77.73M.
Innoviva, Inc. (INVA) was downgraded to C+ from B- on 6/9/2022 due to a significant decline in the growth index, total return index and solvency index. The quick ratio declined from 53.77 to 2.84, debt to equity increased from 0.95 to 1.4, and EBIT declined 27.91% from $107.83M to $77.73M.
B
Buy
2/16/2022Upgraded
Innoviva, Inc. (INVA) was upgraded to B- from C+ on 2/16/2022 due to a noticeable increase in the total return index, growth index and volatility index.
Innoviva, Inc. (INVA) was upgraded to B- from C+ on 2/16/2022 due to a noticeable increase in the total return index, growth index and volatility index.
C
Hold
1/25/2022Downgrade
Innoviva, Inc. (INVA) was downgraded to C+ from B- on 1/25/2022 due to a decline in the growth index and total return index. Total revenue declined 2.92% from $100.81M to $97.86M, and EBIT declined 2.06% from $96.54M to $94.55M.
Innoviva, Inc. (INVA) was downgraded to C+ from B- on 1/25/2022 due to a decline in the growth index and total return index. Total revenue declined 2.92% from $100.81M to $97.86M, and EBIT declined 2.06% from $96.54M to $94.55M.
B
Buy
10/6/2021Upgraded
Innoviva, Inc. (INVA) was upgraded to B- from C+ on 10/6/2021 due to a noticeable increase in the total return index and volatility index.
Innoviva, Inc. (INVA) was upgraded to B- from C+ on 10/6/2021 due to a noticeable increase in the total return index and volatility index.
C
Hold
8/24/2021Upgraded
Innoviva, Inc. (INVA) was upgraded to C+ from C on 8/24/2021 due to a significant increase in the growth index, total return index and volatility index. EBIT increased 21.46% from $79.48M to $96.54M, total revenue increased 17.88% from $85.52M to $100.81M, and earnings per share increased from $0.839 to $0.8954.
Innoviva, Inc. (INVA) was upgraded to C+ from C on 8/24/2021 due to a significant increase in the growth index, total return index and volatility index. EBIT increased 21.46% from $79.48M to $96.54M, total revenue increased 17.88% from $85.52M to $100.81M, and earnings per share increased from $0.839 to $0.8954.
C
Hold
1/25/2021Upgraded
Innoviva, Inc. (INVA) was upgraded to C from C- on 1/25/2021 due to an increase in the volatility index.
Innoviva, Inc. (INVA) was upgraded to C from C- on 1/25/2021 due to an increase in the volatility index.
C
Hold
10/15/2020Downgrade
Innoviva, Inc. (INVA) was downgraded to C- from C on 10/15/2020 due to a noticeable decline in the volatility index and total return index.
Innoviva, Inc. (INVA) was downgraded to C- from C on 10/15/2020 due to a noticeable decline in the volatility index and total return index.
C
Hold
8/20/2020Downgrade
Innoviva, Inc. (INVA) was downgraded to C from C+ on 8/20/2020 due to a decline in the total return index and growth index.
Innoviva, Inc. (INVA) was downgraded to C from C+ on 8/20/2020 due to a decline in the total return index and growth index.
C
Hold
8/5/2020Upgraded
Innoviva, Inc. (INVA) was upgraded to C+ from C on 8/5/2020 due to a noticeable increase in the total return index, volatility index and solvency index. Debt to equity declined from 1 to 0.83.
Innoviva, Inc. (INVA) was upgraded to C+ from C on 8/5/2020 due to a noticeable increase in the total return index, volatility index and solvency index. Debt to equity declined from 1 to 0.83.
C
Hold
12/6/2019Upgraded
Innoviva, Inc. (INVA) was upgraded to C from C- on 12/6/2019 due to an increase in the growth index, total return index and volatility index. Earnings per share increased from $0.343 to $0.3612, total revenue increased 2.57% from $64.11M to $65.76M, and EBIT increased 1.73% from $59.76M to $60.79M.
Innoviva, Inc. (INVA) was upgraded to C from C- on 12/6/2019 due to an increase in the growth index, total return index and volatility index. Earnings per share increased from $0.343 to $0.3612, total revenue increased 2.57% from $64.11M to $65.76M, and EBIT increased 1.73% from $59.76M to $60.79M.
C
Hold
9/19/2019Downgrade
Innoviva, Inc. (INVA) was downgraded to C- from C on 9/19/2019 due to a noticeable decline in the volatility index and total return index.
Innoviva, Inc. (INVA) was downgraded to C- from C on 9/19/2019 due to a noticeable decline in the volatility index and total return index.
C
Hold
7/18/2019Downgrade
Innoviva, Inc. (INVA) was downgraded to C from C+ on 7/18/2019 due to a large decline in the growth index, volatility index and solvency index. Earnings per share declined from $2.3405 to $0.3105, EBIT declined 35.77% from $81.21M to $52.17M, and total revenue declined 30.9% from $79.86M to $55.18M.
Innoviva, Inc. (INVA) was downgraded to C from C+ on 7/18/2019 due to a large decline in the growth index, volatility index and solvency index. Earnings per share declined from $2.3405 to $0.3105, EBIT declined 35.77% from $81.21M to $52.17M, and total revenue declined 30.9% from $79.86M to $55.18M.
C
Hold
4/23/2019Downgrade
Innoviva, Inc. (INVA) was downgraded to C+ from B- on 4/23/2019 due to a decline in the total return index and volatility index.
Innoviva, Inc. (INVA) was downgraded to C+ from B- on 4/23/2019 due to a decline in the total return index and volatility index.
B
Buy
4/3/2019Downgrade
Innoviva, Inc. (INVA) was downgraded to B- from B on 4/3/2019 due to a decline in the total return index.
Innoviva, Inc. (INVA) was downgraded to B- from B on 4/3/2019 due to a decline in the total return index.
B
Buy
10/24/2018Upgraded
Innoviva, Inc. (INVA) was upgraded to B from B- on 10/24/2018 due to an increase in the total return index, volatility index and valuation index.
Innoviva, Inc. (INVA) was upgraded to B from B- on 10/24/2018 due to an increase in the total return index, volatility index and valuation index.
B
Buy
10/10/2018Upgraded
Innoviva, Inc. (INVA) was upgraded to B- from C+ on 10/10/2018 due to an increase in the valuation index, volatility index and growth index. Earnings per share increased from $0.2729 to $0.4942, EBIT increased 42.78% from $43.9M to $62.68M, and total revenue increased 28.08% from $52.38M to $67.09M.
Innoviva, Inc. (INVA) was upgraded to B- from C+ on 10/10/2018 due to an increase in the valuation index, volatility index and growth index. Earnings per share increased from $0.2729 to $0.4942, EBIT increased 42.78% from $43.9M to $62.68M, and total revenue increased 28.08% from $52.38M to $67.09M.
C
Hold
5/1/2018Downgrade
Innoviva, Inc. (INVA) was downgraded to C+ from B- on 5/1/2018 due to a decline in the total return index.
Innoviva, Inc. (INVA) was downgraded to C+ from B- on 5/1/2018 due to a decline in the total return index.
B
Buy
2/28/2018Upgraded
Innoviva, Inc. (INVA) was upgraded to B- from C+ on 2/28/2018 due to a major increase in the growth index, volatility index and total return index. Earnings per share increased from $0.2102 to $0.5017, EBIT increased 50.3% from $42.52M to $63.91M, and total revenue increased 42.92% from $48.64M to $69.52M.
Innoviva, Inc. (INVA) was upgraded to B- from C+ on 2/28/2018 due to a major increase in the growth index, volatility index and total return index. Earnings per share increased from $0.2102 to $0.5017, EBIT increased 50.3% from $42.52M to $63.91M, and total revenue increased 42.92% from $48.64M to $69.52M.
C
Hold
12/4/2017Upgraded
Innoviva, Inc. (INVA) was upgraded to C+ from C on 12/4/2017 due to an increase in the total return index, valuation index and efficiency index. Total capital increased 6.53% from $357.16M to $380.49M.
Innoviva, Inc. (INVA) was upgraded to C+ from C on 12/4/2017 due to an increase in the total return index, valuation index and efficiency index. Total capital increased 6.53% from $357.16M to $380.49M.
C
Hold
11/2/2017Downgrade
Innoviva, Inc. (INVA) was downgraded to C from C+ on 11/2/2017 due to a decline in the volatility index.
Innoviva, Inc. (INVA) was downgraded to C from C+ on 11/2/2017 due to a decline in the volatility index.
C
Hold
10/5/2017Upgraded
Innoviva, Inc. (INVA) was upgraded to C+ from C on 10/5/2017 due to a large increase in the valuation index, growth index and efficiency index. Net income increased 108.64% from $16.85M to $35.15M, earnings per share increased from $0.1517 to $0.3035, and EBIT increased 63% from $29.34M to $47.83M.
Innoviva, Inc. (INVA) was upgraded to C+ from C on 10/5/2017 due to a large increase in the valuation index, growth index and efficiency index. Net income increased 108.64% from $16.85M to $35.15M, earnings per share increased from $0.1517 to $0.3035, and EBIT increased 63% from $29.34M to $47.83M.
C
Hold
3/3/2017Upgraded
Innoviva, Inc. (INVA) was upgraded to C from C- on 3/3/2017 due to a significant increase in the valuation index, efficiency index and total return index. Net income increased 69.43% from $15.03M to $25.47M, and total capital increased 2.24% from $355.14M to $363.1M.
Innoviva, Inc. (INVA) was upgraded to C from C- on 3/3/2017 due to a significant increase in the valuation index, efficiency index and total return index. Net income increased 69.43% from $15.03M to $25.47M, and total capital increased 2.24% from $355.14M to $363.1M.
C
Hold
10/31/2016Upgraded
Innoviva, Inc. (INVA) was upgraded to C- from D+ on 10/31/2016 due to an increase in the total return index and valuation index.
Innoviva, Inc. (INVA) was upgraded to C- from D+ on 10/31/2016 due to an increase in the total return index and valuation index.
D
Sell
9/26/2016Downgrade
Innoviva, Inc. (INVA) was downgraded to D+ from C- on 9/26/2016 due to a decline in the total return index.
Innoviva, Inc. (INVA) was downgraded to D+ from C- on 9/26/2016 due to a decline in the total return index.
C
Hold
8/18/2016Upgraded
Innoviva, Inc. (INVA) was upgraded to C- from D+ on 8/18/2016 due to an increase in the growth index, valuation index and efficiency index. Net income increased 229.13% from $4.44M to $14.6M, earnings per share increased from $0.0394 to $0.1291, and operating cash flow increased 71.86% from $7.25M to $12.46M.
Innoviva, Inc. (INVA) was upgraded to C- from D+ on 8/18/2016 due to an increase in the growth index, valuation index and efficiency index. Net income increased 229.13% from $4.44M to $14.6M, earnings per share increased from $0.0394 to $0.1291, and operating cash flow increased 71.86% from $7.25M to $12.46M.
D
Sell
5/6/2016Upgraded
Innoviva, Inc. (INVA) was upgraded to D+ from D on 5/6/2016 due to a large increase in the growth index, total return index and efficiency index. Total revenue increased 5.87% from $22.84M to $24.18M, earnings per share increased from $0.0373 to $0.0394, and operating cash flow increased 4.81% from $6.92M to $7.25M.
Innoviva, Inc. (INVA) was upgraded to D+ from D on 5/6/2016 due to a large increase in the growth index, total return index and efficiency index. Total revenue increased 5.87% from $22.84M to $24.18M, earnings per share increased from $0.0373 to $0.0394, and operating cash flow increased 4.81% from $6.92M to $7.25M.
D
Sell
3/11/2016Downgrade
Innoviva, Inc. (INVA) was downgraded to D from C- on 3/11/2016 due to a major decline in the volatility index, total return index and dividend index.
Innoviva, Inc. (INVA) was downgraded to D from C- on 3/11/2016 due to a major decline in the volatility index, total return index and dividend index.
C
Hold
1/12/2016Downgrade
Innoviva, Inc. (INVA) was downgraded to C- from C on 1/12/2016 due to a decline in the total return index.
Innoviva, Inc. (INVA) was downgraded to C- from C on 1/12/2016 due to a decline in the total return index.
C
Hold
12/28/2015Upgraded
Theravance Inc. (THRX) was upgraded to C from C- on 12/28/2015 due to a major increase in the efficiency index, growth index and total return index. EBIT increased 65.11% from $5.11M to $8.43M, total revenue increased 27.28% from $10.66M to $13.56M, and operating cash flow increased 22.17% from $2.17M to $2.66M.
Theravance Inc. (THRX) was upgraded to C from C- on 12/28/2015 due to a major increase in the efficiency index, growth index and total return index. EBIT increased 65.11% from $5.11M to $8.43M, total revenue increased 27.28% from $10.66M to $13.56M, and operating cash flow increased 22.17% from $2.17M to $2.66M.
C
Hold
5/11/2015Upgraded
Theravance Inc. (THRX) was upgraded to C- from D+ on 5/11/2015 due to an increase in the growth index, total return index and efficiency index. EBIT increased 473.08% from $130 to $745.
Theravance Inc. (THRX) was upgraded to C- from D+ on 5/11/2015 due to an increase in the growth index, total return index and efficiency index. EBIT increased 473.08% from $130 to $745.
D
Sell
3/2/2015Upgraded
Theravance Inc. (THRX) was upgraded to D+ from D on 3/2/2015 due to a major increase in the growth index, dividend index and efficiency index. Total revenue increased 628.73% from $999 to $7.28M.
Theravance Inc. (THRX) was upgraded to D+ from D on 3/2/2015 due to a major increase in the growth index, dividend index and efficiency index. Total revenue increased 628.73% from $999 to $7.28M.
D
Sell
9/2/2014Downgrade
Theravance Inc. (THRX) was downgraded to D from D+ on 9/2/2014 due to a decline in the solvency index, total return index and volatility index.
Theravance Inc. (THRX) was downgraded to D from D+ on 9/2/2014 due to a decline in the solvency index, total return index and volatility index.
D
Sell
8/11/2014Upgraded
Theravance Inc. (THRX) was upgraded to D+ from D on 8/11/2014 due to an increase in the valuation index, growth index and efficiency index. Total revenue increased 466.06% from $165 to $934, and operating cash flow increased 7.44% from -$50.64M to -$54.41M.
Theravance Inc. (THRX) was upgraded to D+ from D on 8/11/2014 due to an increase in the valuation index, growth index and efficiency index. Total revenue increased 466.06% from $165 to $934, and operating cash flow increased 7.44% from -$50.64M to -$54.41M.
NASDAQ
03/20/2025 2:47PM Eastern
Quotes delayed
